The FDA staff’s view clashes with RFK Jr.’s push to deregulate peptides and move more of them toward Category 1 status.

Earlier this year, when US telehealth giant Hims & Hers first unveiled plans to acquire its Australian rival Eucalyptus for a ...

Hims had 2.6 million subscribers in Q1, up 9% year over year, with Q2 expected to show how much the Novo deal is helping ...

The stock is already showing accelerating fundamentals (33% LTM revenue growth, 73% gross margin) plus credible weight-loss distribution via Novo Nordisk’s largest telehealth partner. The market is ...

Committee will meet in July to discuss peptides now sold in gray market despite limited evidence of safety and efficacy ...

Estrogen patches are in short supply as demand for menopause treatments skyrockets, and it could take at least a year for ...

The first Enhanced Games, where PED use was encouraged, ended with only one world record beaten. But the athletes collected ...

The Forbes' World's Most Influential CMOs 2026 list recognizes chief marketers whose approach to driving growth is charting ...

Deutsche Bank AG DB has entered into a definitive agreement to sell its retail banking, affluent private banking and wealth management business in India to Kotak Mahindra Bank ("Kotak"). The agreement ...

Detailed price information for The Charles Schwab Corp (SCHW-N) from The Globe and Mail including charting and trades.

CANOPY reports that creators are shifting from Hollywood to coworking spaces for production, valuing community, resources, ...

(Corrects paragraph 15 to reflect that Hims & Hers is one of the most volume-producing of Novo’s partners, and not the most ...